ITEM 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On April 6, 2016, OxySure Therapeutics, Inc. (the “Company” or “OxySure”) filed an as corrected amendment to Article Four of the Company’s Articles of Incorporation with the Secretary of State in Delaware. Pursuant to the certificate of amendment (the “Reverse Split Certificate of Amendment”), the Company effected a reverse split at a ratio of 1-for-50. The Reverse Split Certificate of Amendment is attached hereto as Exhibit 3.1 and incorporated herein by reference.
In addition, the Company filed an as corrected amendment to Section 4.01 of Article Four of the Company’s Articles of Incorporation. Pursuant to the certificate of amendment (“Share Change Certificate of Amendment”) the Company increased the authorized shares of the Company’s common stock, par value $0.0004 per share (“Common Stock”) to 500,000,000 shares. The Share Change Certificate of Amendment is attached hereto as Exhibit 3.2 and incorporated herein by reference. No other amendments were made to the Company’s Articles of Incorporation.
